Goldman Sachs’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.88M Buy
1,090,599
+290,823
+36% +$2.62M ﹤0.01% 3386
2025
Q4
$8.55M Buy
799,776
+105,470
+15% +$1.16M ﹤0.01% 3250
2025
Q3
$8.65M Buy
694,306
+131,293
+23% +$1.35M ﹤0.01% 3105
2025
Q2
$5.75M Sell
563,013
-159,093
-22% -$1.4M ﹤0.01% 3283
2025
Q1
$5.7M Sell
722,106
-180,446
-20% -$2.22M ﹤0.01% 3226
2024
Q4
$7.09M Sell
902,552
-56,122
-6% -$282K ﹤0.01% 3104
2024
Q3
$3.02M Buy
958,674
+259,947
+37% +$765K ﹤0.01% 3781
2024
Q2
$1.98M Buy
698,727
+540,233
+341% +$3.85M ﹤0.01% 3932
2024
Q1
$2.5M Sell
158,494
-122,582
-44% -$2.07M ﹤0.01% 3698
2023
Q4
$5.53M Buy
281,076
+141,502
+101% +$2.46M ﹤0.01% 3068
2023
Q3
$2.84M Sell
139,574
-11,987
-8% -$301K ﹤0.01% 3480
2023
Q2
$4.43M Buy
151,561
+36,080
+31% +$989K ﹤0.01% 3206
2023
Q1
$3.24M Sell
115,481
-882
-0.8% -$22.6K ﹤0.01% 3454
2022
Q4
$2.16M Sell
116,363
-591,866
-84% -$10.1M ﹤0.01% 3888
2022
Q3
$11.2M Sell
708,229
-55,183
-7% -$1.24M ﹤0.01% 2406
2022
Q2
$19.3M Buy
763,412
+443,219
+138% +$13.3M ﹤0.01% 1927
2022
Q1
$11.6M Sell
320,193
-218,138
-41% -$10.7M ﹤0.01% 2550
2021
Q4
$41.3M Sell
538,331
-20,403
-4% -$1.8M 0.01% 1506
2021
Q3
$53.7M Sell
558,734
-21,175
-4% -$2.31M 0.01% 1233
2021
Q2
$61.9M Buy
579,909
+227,786
+65% +$22.4M 0.01% 1089
2021
Q1
$31.5M Buy
352,123
+204,072
+138% +$22.5M 0.01% 1542
2020
Q4
$14.9M Buy
148,051
+60,469
+69% +$4.51M ﹤0.01% 2112
2020
Q3
$4.28M Sell
87,582
-142,115
-62% -$6.82M ﹤0.01% 3029
2020
Q2
$9.38M Buy
229,697
+44,307
+24% +$1.27M ﹤0.01% 2325
2020
Q1
$2.85M Sell
185,390
-29,559
-14% -$621K ﹤0.01% 3063
2019
Q4
$4.87M Buy
+214,949
New +$3.53M ﹤0.01% 2986

Other funds holding CRNC

Goldman Sachs's CRNC Position: Q1 2026 in Review

Goldman Sachs increased its Cerence (CRNC) stake by 36% in Q1 2026, buying an estimated $2.62M and bringing the position to 1,090,599 shares worth $6.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3386.

Goldman Sachs first reported a position in CRNC in Q4 2019 and has held it in 26 quarters since. The position peaked at $61.9M in Q2 2021. 195 funds tracked by Wall St. Rank hold CRNC as of Q1 2026.

  • Goldman Sachs held 1,090,599 shares of Cerence worth $6.88M as of Q1 2026.
  • Goldman Sachs bought 290,823 Cerence shares in Q1 2026, an estimated $2.62M.
  • Cerence made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3386 holding.
  • Goldman Sachs first reported a position in Cerence in Q4 2019 and has held it in 26 quarters since.
  • Goldman Sachs's Cerence position peaked at $61.9M in Q2 2021.
  • 195 funds tracked by Wall St. Rank held Cerence as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.